Clinical significance of immunohistochemical expression of insulin-like growth factor-1 receptor and matrix metalloproteinase-7 in resected non-small cell lung cancer

By Yamamoto Taketsugu   Oshima Takashi   Yoshihara Kazue   Nishi Teppei   Arai Hiromasa   Inui Kenji   Kaneko Takeshi   Nozawa Akinori   Adachi Hiroyuki   Rino Yasushi   Masuda Munetaka   Imada Toshio  

Experimental and Therapeutic Medicine, Vol. 3, Iss. 5, 2012-05 ,pp. : 797-802

Spandidos Publications

Access to resources Recommend Favorite

Clinical implications of insulin-like growth factor II mRNA-binding protein 3 expression in non-small cell lung carcinoma

By                    

Oncology Letters, Vol. 9, Iss. 4, 2015-01 ,pp. : 1927-1933

Spandidos Publications

Access to resources Recommend Favorite

Combined inhibition of insulin-like growth factor-1 receptor enhances the effects of gefitinib in a human non-small cell lung cancer resistant cell line

By Qi Hui wei   Shen Zan   Fan Li hong  

Experimental and Therapeutic Medicine, Vol. 2, Iss. 6, 2011-11 ,pp. : 1091-1095

Spandidos Publications

Access to resources Recommend Favorite

Mutational analysis of the insulinlike growth factor 1 receptor tyrosine kinase domain in non-small cell lung cancer patients

By              

Molecular and Clinical Oncology, Vol. 3, Iss. 5, 2015-01 ,pp. : 1073-1079

Science Publishers

Access to resources Recommend Favorite

Celecoxib inhibits insulin-like growth factor 1 induced growth and invasion in non-small cell lung cancer

By            

Oncology Letters, Vol. 5, Iss. 6, 2013-01 ,pp. : 1943-1947

Spandidos Publications

Access to resources Recommend Favorite